相关实验视频
Updated: Jul 17, 2025

06:20
Syngeneic Mouse Orthotopic Allografts to Model Pancreatic Cancer
Published on: October 4, 2022
2.8K
胰腺癌转移的表观遗传控制
Lukas Krauß1, Carolin Schneider2, Elisabeth Hessmann3,4,5
1Department of General, Visceral and Pediatric Surgery, University Medical Center Göttingen, 37075, Göttingen, Germany. lukas.krauss@med.uni-goettingen.de.
Cancer metastasis reviews
|September 2, 2023
概括
本综述探讨了表观遗传变化如何驱动胰腺癌转移. 向基因组修饰酶提供了一种有前途的策略,以改善治疗结果并防止癌症复发.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
背景情况:
- 胰腺管腺癌 (PDAC) 的存活率通过手术和化疗得到改善,但转移限制了超过50%的患者的治疗可行性.
- PDAC中的转移是一个复杂的过程,转录和表观遗传可塑性成为关键驱动因素.
- 表观遗传重编程干扰可以控制适应过程,提高治疗效率并防止复发.
研究的目的:
- 审查基因组修饰酶在胰腺癌转移中的作用.
- 为了突出这些酶对转移级联的影响.
- 为胰腺癌的表观遗传疗法提供临床发展的最新信息.
主要方法:
- 文献综述侧重于PDAC转移中的表观遗传机制.
- 分析基因组修饰酶在癌症进展中的作用.
- 对当前临床试验和表观遗传疗法进展的调查.
主要成果:
- 基素修饰酶显著影响胰腺癌的转移级联.
- 表观遗传可塑性有助于转移性进展和治疗耐药性.
- 新兴的表观遗传疗法显示出改善患者治疗结果的潜力.
结论:
- 向基因组修饰酶是对抗PDAC转移的一个有希望的策略.
- 表观遗传重编程为胰腺癌提供了一种新的治疗途径.
- 对表观遗传疗法的进一步临床开发是有必要的,以提高生存率.
相关概念视频
Epigenetic Regulation
3.1K
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
X-chromosome...
3.1K
Metastasis
5.6K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.6K
Cell Specific Gene Expression
13.6K
Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...
13.6K
Genomic Imprinting and Inheritance
34.6K
Diploid organisms inherit genetic material through chromosomes from both parents. Copies of the same gene are known as alleles. In most cases, both alleles are simultaneously expressed and allow various cellular processes to function optimally. If one of the alleles is missing or mutated, the expression of the other allele can compensate; however, this is not true for all genes.
The expression of some genes depends on which parent passed the gene to the offspring, through a phenomenon known as...
The expression of some genes depends on which parent passed the gene to the offspring, through a phenomenon known as...
34.6K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Induced Pluripotent Stem Cells
4.2K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
4.2K

